Inflammatory Bowel Disease Market Forecast
This model provides detailed sales and volume forecast data for the inflammatory bowel disease market. Including Crohn's disease and ulcerative colitis market sizing, within the context of total brand sales across the seven major markets.Reasons to Purchase
- Quantify the current size of IBD sales in the seven major markets and understand trends in the rest of the world
- Understand IBD market trends and assess the impact of events, such as biosimilars entry, on sales of over 30 key brand name products
- Access a case study assessing the likelihood of ulcerative colitis approval for Humira and Simponi with three alternative scenario forecasts
Related Reports
- Forecast Insight: Inflammatory Bowel Disease - New product launches sustain long-term market growth
- Commercial Insight: Inflammatory Bowel Disease Future market prospects rely on addressing cost and safety
- Pipeline Insight: Inflammatory Bowel Disease - Varied drug targets to broaden future therapy options
- Inflammatory Bowel Disease Therapy Area Pipeline Report
- Digestive System Inflammatory Bowel Disease Therapy Area Pipeline Report
- Irritable Bowel Syndrome - Pipeline Assessment and Market Forecasts to 2017
- Irritable Bowel Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016
- The Future of Parenteral Nutrition: Key players, disease specific opportunities and market forecasts
- Parkinson's Disease Market Forecast
- Chronic Kidney Disease - Pipeline Assessment and Market Forecasts to 2016
